| Literature DB >> 27045272 |
Zhiyong Wen1, Xiaona Li1, Daiying Zuo2, Binyue Lang2, Yang Wu1, Mingyang Jiang1, Huizhuo Ma1, Kai Bao1,3, Yingliang Wu2, Weige Zhang1.
Abstract
A series of 3-(3'-hydroxy-4'-methoxyphenyl)selenyl-5,6,7-trimethoxy-1H-indoles and 3-(3'-hydroxy-4'-methoxyphenyl)thio-5,6,7-trimethoxy-1H-indoles were obtained as a new class of combretastatin A-4 (CA-4) analogues via a convenient ultrasound (US)-assisted two-step process involving 3-selenenylation/sulfenylation followed by O-deallylation. With the assistance of US irradiation, both the reaction rates and yields of selenenylation, sulfenylation and O-deallylation could be significantly improved. A comparison of the reaction rates of O-deallylation and ester reduction demonstrated that O-deallylation was more sensitive to US irradiation. Finally, these products were evaluated for their antiproliferative activities, and most of them showed moderate to potent activities against three human cancer cell lines in vitro.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27045272 PMCID: PMC4820744 DOI: 10.1038/srep23986
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The structures of CA-4 (1a), CA-4P (1b), the analogues (2–5) and the general structure of target compounds (6).
The optimization of conditions for the preparation of compound 9a.
aFe2(SO4)3.5H2O (20 mol%) was used instead of FeCl3.
bisolated yield.
Synthesis of compounds 9b–h.
aUS: 25 °C, 9 h.
bNon-US: 80 °C, 20 h.
cisolated yield.
The optimization of conditions for the preparation of compound 10a.
aNon-US: 25 °C.
bUS: 25 °C.
cisolated yield.
O-Deallylations of compounds 10b–h.
aisolated yield.
bUS: 25 °C, 3 h.
cNon-US: 25 °C, 15 h.
dThe highest yield (90%) was obtained under US irradiation at 25 °C for 1.3 h.
eThe highest yield (65%) was obtained under US irradiation at 25 °C for 2 h.
Figure 2Comparison of O-Deallylation and ester reduction of 9d, 9g under non-US and US conditions.
(a) Experiments of O-deallylation and ester reduction of 9d, 9g. (b) HPLC analysis of O-deallylation and ester reduction of 9d under non-US and US conditions.
Figure 3Comparison of O-deallylation of 9b and ester reduction of 7d under non-US and US conditions.
(a) Experiments of 9b and 7d. (b) HPLC analysis of O-deallylation of 9b and ester reduction of 7d under non-US and US conditions.
The in vitro antiproliferative activities of the synthesized compounds against three human cancer cell lines.
| Compound | IC50 | ||
|---|---|---|---|
| SGC7901 | KB | HT1080 | |
| 10a | 0.054 ± 0.009 | 0.025 ± 0.003 | 0.014 ± 0.002 |
| 10b | 0.22 ± 0.03 | 0.64 ± 0.05 | 1.0 ± 0.2 |
| 10c | 14.92 ± 1.8 | 7.82 ± 0.6 | 12.55 ± 1.1 |
| 10d | 22.04 ± 1.5 | 17.69 ± 1.1 | >500 |
| 10e | 10.56 ± 1.1 | 11.72 ± 0.8 | 18.68 ± 2.2 |
| 10f | >500 | >500 | >500 |
| 10g | >500 | 278.4 ± 22 | >500 |
| 10h | 23.78 ± 1.2 | 5.45 ± 0.8 | 16.70 ± 1.2 |
| CA-4 | 0.011 ± 0.0012 | 0.004 ± 0.0007 | 0.011 ± 0.0018 |
aIC50, expressed as the concentration of drug inhibiting cell growth by 50%. Data are expressed as means ± SDs (standard deviations).
bn = 4.
cn = 3.
Figure 4Compound 10a and CA-4 induce microtubules depolymerization in HT-1080 cells.
HT-1080 cells were treated with CA-4 (11 nM) or compound 10a (14 nM) for 24 h. Cells were fixed and stained with monoclonal α-tubulin (green) and counterstained with DAPI (blue). Immunofluorescence was detected using a fluorescence microscope (Olympus, Tokyo, Japan, bar scale 50 μm).